Your browser doesn't support javascript.
loading
Characteristics of patients with severe asthma who experienced treatment failure with omalizumab.
Akaba, Tomohiro; Kondo, Mitsuko; Kobayashi, Fumi; Honda, Nahoko; Muramatsu, Soshi; Yagi, Osamitsu; Takeyama, Kiyoshi; Seo, Yukako; Nonaka, Manabu; Tagaya, Etsuko.
Afiliação
  • Akaba T; Department of Respiratory Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; Allergy Medical Center, Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Kondo M; Department of Respiratory Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; Allergy Medical Center, Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Kobayashi F; Department of Respiratory Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; Allergy Medical Center, Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Honda N; Department of Respiratory Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; Allergy Medical Center, Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Muramatsu S; Department of Respiratory Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; Allergy Medical Center, Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Yagi O; Department of Respiratory Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; Allergy Medical Center, Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Takeyama K; Department of Respiratory Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; Allergy Medical Center, Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Seo Y; Department of Otolaryngology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; Allergy Medical Center, Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Nonaka M; Department of Otolaryngology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; Allergy Medical Center, Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Tagaya E; Department of Respiratory Medicine, Tokyo Women's Medical University School of Medicine, Tokyo, Japan; Allergy Medical Center, Tokyo Women's Medical University Hospital, Tokyo, Japan. Electronic address: tagaya.etsuko@twmu.ac.jp.
Pulm Pharmacol Ther ; 68: 102032, 2021 06.
Article em En | MEDLINE | ID: mdl-33862220

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Revista: Pulm Pharmacol Ther Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Asma / Antiasmáticos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans Idioma: En Revista: Pulm Pharmacol Ther Assunto da revista: FARMACOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Japão